Clinicians’ experiences with the fragile X clinical and research consortium

Jessica A. Liu, Randi J Hagerman, Robert M. Miller, Lisa T. Craft, Brenda Finucane, Nicole Tartaglia, Elizabeth M. Berry-Kravis, Stephanie L. Sherman, Sharon A. Kidd, Jeffrey Cohen

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The objectives of the study were to assess the attitudes and experiences of clinicians involved in a consortium of clinics serving people with fragile X-associated disorders to gauge satisfaction with the consortium and its efforts to improve quality of life for patients and the community. An internet survey was sent to 26 fragile X (FX) clinic directors participating in the Fragile X Clinical and Research Consortium (FXCRC). Respondents were asked to complete 19 questions on consortium performance and outcomes relevant for their own clinic. The response rate was 84% (22/26), with two surveys providing incomplete data. Assistance with clinic establishment, opportunities for research collaborations, and access to colleagues and information were highly valued. Approximately 76% of clinicians reported improvements in patient care and 60% reported an increase in patient services. There was a 57% increase in participation in a FX-related clinical trial among clinics since joining the FXCRC (24% vs. 81%). Overall, respondents reported primarily positive experiences from participation in the FXCRC. Common suggestions for improvement included additional financial support and increased utilization of collected patient data for research purposes. Additionally, a Clinic Services Checklist was administered annually to examine changes in services offered over time. There were several important changes regarding the provision of services by clinics, often with multiple clinics changing with respect to a service. In conclusion, the FXCRC has led to the establishment and sustainment of fragile X clinics in the U.S., fostered cooperation among fragile X clinicians, and provided clinics with a platform to share recommendations and best practices to maximize quality of life for their patients and the overall fragile X community. The results from the survey and checklist also provide suggestions to strengthen the FXCRC and enhance future collaborations among FXCRC members.

Original languageEnglish (US)
Pages (from-to)3138-3143
Number of pages6
JournalAmerican Journal of Medical Genetics, Part A
Volume170
Issue number12
DOIs
StatePublished - Dec 1 2016

Fingerprint

Research
Checklist
Quality of Life
Financial Support
Access to Information
Practice Guidelines
Internet
Patient Care
Surveys and Questionnaires
Clinical Trials

Keywords

  • consortium
  • fragile X syndrome
  • intellectual and developmental disabilities
  • survey

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Liu, J. A., Hagerman, R. J., Miller, R. M., Craft, L. T., Finucane, B., Tartaglia, N., ... Cohen, J. (2016). Clinicians’ experiences with the fragile X clinical and research consortium. American Journal of Medical Genetics, Part A, 170(12), 3138-3143. https://doi.org/10.1002/ajmg.a.37948

Clinicians’ experiences with the fragile X clinical and research consortium. / Liu, Jessica A.; Hagerman, Randi J; Miller, Robert M.; Craft, Lisa T.; Finucane, Brenda; Tartaglia, Nicole; Berry-Kravis, Elizabeth M.; Sherman, Stephanie L.; Kidd, Sharon A.; Cohen, Jeffrey.

In: American Journal of Medical Genetics, Part A, Vol. 170, No. 12, 01.12.2016, p. 3138-3143.

Research output: Contribution to journalArticle

Liu, JA, Hagerman, RJ, Miller, RM, Craft, LT, Finucane, B, Tartaglia, N, Berry-Kravis, EM, Sherman, SL, Kidd, SA & Cohen, J 2016, 'Clinicians’ experiences with the fragile X clinical and research consortium', American Journal of Medical Genetics, Part A, vol. 170, no. 12, pp. 3138-3143. https://doi.org/10.1002/ajmg.a.37948
Liu, Jessica A. ; Hagerman, Randi J ; Miller, Robert M. ; Craft, Lisa T. ; Finucane, Brenda ; Tartaglia, Nicole ; Berry-Kravis, Elizabeth M. ; Sherman, Stephanie L. ; Kidd, Sharon A. ; Cohen, Jeffrey. / Clinicians’ experiences with the fragile X clinical and research consortium. In: American Journal of Medical Genetics, Part A. 2016 ; Vol. 170, No. 12. pp. 3138-3143.
@article{78f6447084d14373a7964dd2d0061808,
title = "Clinicians’ experiences with the fragile X clinical and research consortium",
abstract = "The objectives of the study were to assess the attitudes and experiences of clinicians involved in a consortium of clinics serving people with fragile X-associated disorders to gauge satisfaction with the consortium and its efforts to improve quality of life for patients and the community. An internet survey was sent to 26 fragile X (FX) clinic directors participating in the Fragile X Clinical and Research Consortium (FXCRC). Respondents were asked to complete 19 questions on consortium performance and outcomes relevant for their own clinic. The response rate was 84{\%} (22/26), with two surveys providing incomplete data. Assistance with clinic establishment, opportunities for research collaborations, and access to colleagues and information were highly valued. Approximately 76{\%} of clinicians reported improvements in patient care and 60{\%} reported an increase in patient services. There was a 57{\%} increase in participation in a FX-related clinical trial among clinics since joining the FXCRC (24{\%} vs. 81{\%}). Overall, respondents reported primarily positive experiences from participation in the FXCRC. Common suggestions for improvement included additional financial support and increased utilization of collected patient data for research purposes. Additionally, a Clinic Services Checklist was administered annually to examine changes in services offered over time. There were several important changes regarding the provision of services by clinics, often with multiple clinics changing with respect to a service. In conclusion, the FXCRC has led to the establishment and sustainment of fragile X clinics in the U.S., fostered cooperation among fragile X clinicians, and provided clinics with a platform to share recommendations and best practices to maximize quality of life for their patients and the overall fragile X community. The results from the survey and checklist also provide suggestions to strengthen the FXCRC and enhance future collaborations among FXCRC members.",
keywords = "consortium, fragile X syndrome, intellectual and developmental disabilities, survey",
author = "Liu, {Jessica A.} and Hagerman, {Randi J} and Miller, {Robert M.} and Craft, {Lisa T.} and Brenda Finucane and Nicole Tartaglia and Berry-Kravis, {Elizabeth M.} and Sherman, {Stephanie L.} and Kidd, {Sharon A.} and Jeffrey Cohen",
year = "2016",
month = "12",
day = "1",
doi = "10.1002/ajmg.a.37948",
language = "English (US)",
volume = "170",
pages = "3138--3143",
journal = "American Journal of Medical Genetics",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "12",

}

TY - JOUR

T1 - Clinicians’ experiences with the fragile X clinical and research consortium

AU - Liu, Jessica A.

AU - Hagerman, Randi J

AU - Miller, Robert M.

AU - Craft, Lisa T.

AU - Finucane, Brenda

AU - Tartaglia, Nicole

AU - Berry-Kravis, Elizabeth M.

AU - Sherman, Stephanie L.

AU - Kidd, Sharon A.

AU - Cohen, Jeffrey

PY - 2016/12/1

Y1 - 2016/12/1

N2 - The objectives of the study were to assess the attitudes and experiences of clinicians involved in a consortium of clinics serving people with fragile X-associated disorders to gauge satisfaction with the consortium and its efforts to improve quality of life for patients and the community. An internet survey was sent to 26 fragile X (FX) clinic directors participating in the Fragile X Clinical and Research Consortium (FXCRC). Respondents were asked to complete 19 questions on consortium performance and outcomes relevant for their own clinic. The response rate was 84% (22/26), with two surveys providing incomplete data. Assistance with clinic establishment, opportunities for research collaborations, and access to colleagues and information were highly valued. Approximately 76% of clinicians reported improvements in patient care and 60% reported an increase in patient services. There was a 57% increase in participation in a FX-related clinical trial among clinics since joining the FXCRC (24% vs. 81%). Overall, respondents reported primarily positive experiences from participation in the FXCRC. Common suggestions for improvement included additional financial support and increased utilization of collected patient data for research purposes. Additionally, a Clinic Services Checklist was administered annually to examine changes in services offered over time. There were several important changes regarding the provision of services by clinics, often with multiple clinics changing with respect to a service. In conclusion, the FXCRC has led to the establishment and sustainment of fragile X clinics in the U.S., fostered cooperation among fragile X clinicians, and provided clinics with a platform to share recommendations and best practices to maximize quality of life for their patients and the overall fragile X community. The results from the survey and checklist also provide suggestions to strengthen the FXCRC and enhance future collaborations among FXCRC members.

AB - The objectives of the study were to assess the attitudes and experiences of clinicians involved in a consortium of clinics serving people with fragile X-associated disorders to gauge satisfaction with the consortium and its efforts to improve quality of life for patients and the community. An internet survey was sent to 26 fragile X (FX) clinic directors participating in the Fragile X Clinical and Research Consortium (FXCRC). Respondents were asked to complete 19 questions on consortium performance and outcomes relevant for their own clinic. The response rate was 84% (22/26), with two surveys providing incomplete data. Assistance with clinic establishment, opportunities for research collaborations, and access to colleagues and information were highly valued. Approximately 76% of clinicians reported improvements in patient care and 60% reported an increase in patient services. There was a 57% increase in participation in a FX-related clinical trial among clinics since joining the FXCRC (24% vs. 81%). Overall, respondents reported primarily positive experiences from participation in the FXCRC. Common suggestions for improvement included additional financial support and increased utilization of collected patient data for research purposes. Additionally, a Clinic Services Checklist was administered annually to examine changes in services offered over time. There were several important changes regarding the provision of services by clinics, often with multiple clinics changing with respect to a service. In conclusion, the FXCRC has led to the establishment and sustainment of fragile X clinics in the U.S., fostered cooperation among fragile X clinicians, and provided clinics with a platform to share recommendations and best practices to maximize quality of life for their patients and the overall fragile X community. The results from the survey and checklist also provide suggestions to strengthen the FXCRC and enhance future collaborations among FXCRC members.

KW - consortium

KW - fragile X syndrome

KW - intellectual and developmental disabilities

KW - survey

UR - http://www.scopus.com/inward/record.url?scp=84995768719&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995768719&partnerID=8YFLogxK

U2 - 10.1002/ajmg.a.37948

DO - 10.1002/ajmg.a.37948

M3 - Article

C2 - 27604509

AN - SCOPUS:84995768719

VL - 170

SP - 3138

EP - 3143

JO - American Journal of Medical Genetics

JF - American Journal of Medical Genetics

SN - 1552-4825

IS - 12

ER -